Cargando…
Diagnostic Strategies for Early Recognition of Cancer Therapeutics–Related Cardiac Dysfunction
Cardiovascular toxicity in the form of cardiac dysfunction continues to be an obstacle for patients with cancer. Survival and quality of life of cancer survivors are frequently affected by increased incidence of cardiovascular disease. The involvement of the cardiovascular system by primary or secon...
Autores principales: | Manrique, Carlos R, Park, Michael, Tiwari, Nidhish, Plana, Juan Carlos, Garcia, Mario J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392033/ https://www.ncbi.nlm.nih.gov/pubmed/28469492 http://dx.doi.org/10.1177/1179546817697983 |
Ejemplares similares
-
Diagnostic accuracy of cardiac testing for coronary artery disease in potential liver transplant recipients: A systematic review and meta-analysis
por: Tiwari, Nidhish, et al.
Publicado: (2021) -
Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
por: Huang, Yafei, et al.
Publicado: (2023) -
Case report: Use of unenhanced cardiac MR to evaluate low flow states for thrombus
por: Levin, Avinoam, et al.
Publicado: (2022) -
Early diagnostic value of high‐sensitivity cardiac troponin T for cancer treatment‐related cardiac dysfunction: a meta‐analysis
por: Lv, Xinfang, et al.
Publicado: (2023) -
Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis
por: Imamura, Teruhiko, et al.
Publicado: (2021)